---
tags:
  - Pharmacology
edited: 2024-01-24
---
### Principles
- Combination therapy is used to prevent resistance
- Tailor according to HIV genotype if needed
- Establish regular monitoring for response

### Drug regimen
| **Regimen**        | **Recommended Drug Combinations**                                                              | **Combination Tablet** | **Indications/Contraindications**                                                                                                                                                                                              |
| ------------------ | ---------------------------------------------------------------------------------------------- | ---------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| 2 NRTIs PLUS 1 INI | Bictegravir + Tenofovir alafenamide + Emtricitabine                                            | Biktarvy®              | May be used for immediate treatment in individuals for whom advanced HIV studies are not yet available and whose hepatitis B status is unknown                                                                                 |
|                    | Dolutegravir + (Tenofovir alafenamide OR Tenofovir disoproxil) + (Emtricitabine OR Lamivudine) |                        |                                                                                                                                                                                                                                |
|                    | Dolutegravir-emtricitabine-tenofovir alafenamide                                               |                        |                                                                                                                                                                                                                                |
|                    | Dolutegravir + Abacavir + Lamivudine                                                           | Triumeq®               | May be used in pregnancy.<br>Contraindicated in patients who are HLA-B*5701 positive.                                                                                                                                          |
| 1 NRTI PLUS 1 INI  | **Dolutegravir + Lamivudine**                                                                  | Dovato®                | This regimen should not be given to patients with:<br>HBV co-infection.<br>HIV RNA > 500,000 copies/mL.<br>If ART is being initiated prior to the availability of results for HIV genotypic resistance testing or HBV testing. |